IM Cannabis completed the acquisition of MYM Nutraceuticals.

IM Cannabis, a Canada-based international medical cannabis company, completed the acquisition of MYM Nutraceuticals, a Canada based company engaged in the business of acquiring and developing natural remedies. Financial terms were not disclosed. “Acquiring MYM is consistent with IMC’s focus on premium and super premium segments of the cannabis market for consumers and patients in all markets. The Transaction also demonstrates our disciplined approach to acquiring accretive companies that create financial and operational synergies and result in additional opportunities to export premium cannabis products to Israel and Germany. With coast-to-coast distribution, including a strong leadership position in Eastern Canada, Highland Grow will further enhance our distribution capabilities and fast-track our entrance into new markets," Oren Shuster, IMC CEO.